binding reactions. Binding reactions were electrophoresed for 20 minutes at 200V through 9% acrylamide (19:1 acrylamide/bisacrylamide) Tris-Borate-EDTA gels containing 15% glycerol.
Gels were imaged on a Typhoon FLA 9500 (GE) and quantified with Image Quant software.
Binding data were fit to a standard Langmuir isotherm using Kaleidagraph fitting software as described previously (4) . Each value is the average of at least 3 (and in many cases [4] [5] [6] [7] [8] replicates, with the error reported being the standard error of the mean.
In vivo analysis of mutant cdc13-DBD¯ strains. Strains bearing cdc13-DBD¯ mutations were constructed by introducing the relevant mutation, in place of one of the two copies of the CDC13 gene in a diploid strain, using a standard integration method as previously described (5) . Correct integration was confirmed by molecular methods (PCR and sequence analysis across the coding region of the gene), to rule out rearrangement of the endogenous locus or unlinked missense mutations. Additional mutations in EXO1, RAD9 and TLC1 were constructed by one-step gene replacement, in which the wild type gene was replaced by a selectable drug-resistant cassette.
Standard growth media and methods were used to propagate yeast strains and generate haploid strains by sporulation of diploid strains and subsequent tetrad dissection. The yeast strains and plasmids used in this study are listed in Tables S3 and S4 , respectively. Specificity Assays. Binding studies to determine the specificity requirements of the Cdc13 DBD mutant proteins were carried out as described above with oligonucleotides randomized individually with equimolar mixtures of the three non-cognate bases at each position in Tel 11 and labeled and diluted as described previously (1, 6). Only one shifted species was observed in all cases, and the binding data were readily fit to a single KD value, consistent with prior data suggesting each alternate base is equally perturbing (6). Per convention, a mixture of A, C, and T is labeled H; a mixture of G, A, and C is labeled V.
Supplemental Materials and Methods:
Circular Dichroism Experiments: Melting curves with Cdc13 DBD constructs were conducted on a Chirascan Plus Spectrometer (Applied Photophysics) scanning from 260 to 190 nm from 20°C to 80°C in 3°C steps allowing 3 minutes of equilibration at each temperature. Buffer conditions were the same as for the Electromobility Shift Assay experiments. Data were processed with Origin graphing software and fit at 222 nm according to Martin and Schilstra (7) to generate the Tm for each construct.
NMR Analysis: NMR data were collected at 32 o C on an Agilent 600 MHz spectrometer equipped with a room temperature HCN probe. HSQC-TROSY spectra were acquired using a BioPack sequence with minor modifications with 180 t1 increments and 120 transients/increment. Spectra were processed using NMRPipe and visualized in CCPNMR Analysis. Assignments were transferred from those previously reported (8).
Strains used for in vivo analysis: The strains used in Fig. S3 expressed cdc13-DBD¯ mutations on single copy CEN plasmids in a cdc13-∆ haploid strain, which allowed inclusion of the cdc13-F539A mutation in these analyses. A mutant strain with the cdc13-F539A mutation integrated into the genome was not viable enough for the experimental manipulations required for parts (B) and C). In contrast, a cdc13-∆ strain expressing the cdc13-F539A mutation from a plasmid exhibited slightly improved growth, sufficient to grow up cultures for analysis (we have previously suggested that an increase in plasmid copy number, due to a selection pressure for viability, is responsible for this slight enhancement in growth; (9)).
Analysis of Cdc13 protein stability in vivo:
Extracts were prepared from a protease-deficient yeast strain transformed with plasmids expressing wild type or mutant Cdc13-(myc)18 proteins, by glass bead disruption; extracts were cleared by 2 x 14,000 rpm at 4° C, resolved on 8% SDS-PAGE gels and probed with anti-myc 9E10 antibody (1:2500), followed by a secondary incubation with IRDye 800CW Goat Anti-Mouse IgG (LiCor) and imaging with LiCor Odyssey.
Detection of hyper-phosphorylated Rad53: Extracts were prepared from cdc13-∆/p CEN LEU2
CDC13 or cdc13-∆/p CEN LEU2 cdc13-F539A strains expressing Rad53-(FLAG)6 which were grown to mid-log phase, pelleted and resuspended in 100µl breaking buffer (50 mM sodium phosphate pH 7.4, 1 mM EDTA, 5% glycerol) plus complete protease inhibitor (Roche). An equal volume of acid-washed glass beads was added and the mixture was vortexed at 4° C for 5 min.
Lysates were clarified by centrifugation at 4° C for 10 min, and treated (or mock-treated) with λ phosphatase (NEB) for 1 hr at 30°. The MMS-treated strain was incubated at 0.1% MMS for 1 hr, immediately prior to extract preparation. Samples were resolved on 6% SDS-PAGE, transferred to nitrocellulose and probed with anti-FLAG antibody (Sigma-Aldrich) at 1:10,000 dilution followed by anti-rabbit IgG HRP conjugate (Promega) at 1:10,000; signal was detected using enhanced chemiluminescence (ECL). hybridization of XhoI-digested genomic DNA with an oligomeric probe specific for the G-rich strand, using native gel electrophoresis (top), followed by in-gel denaturation and rehybridization with the same oligomeric probe (bottom), as described previously (12). Indicated below the native gel is the ratio of native to denatured telomeric restriction fragment signals, normalized to wild type for each genotype; the yku80-Δ strain exhibits a substantial increase in the extent of G-strand ssDNA, consistent with prior observations (13). This analysis was performed with asynchronous cultures as well as with cultures arrested with nocodazole (shown here); the latter condition, in which cells are arrested during a period in the cell cycle when the G-strand ssDNA signal is transiently higher (14), rules out the possibility that a failure to observe a change in single-stranded DNA was due to altered progression through the cell cycle in the cdc13-DBD mutant strains. [mdeg] [mdeg] 
